Table 1 Reporting by Member States on the existence of a written national viral hepatitis strategy or plan
| Â | World Health Organization European sub-region | Total | ||
|---|---|---|---|---|
| Â | West | Centre | East | |
|  | N = 18 (%) | N = 13 (%) | N = 13 (%) | N = 44 (%) |
Existence of a written national strategy or plan that focuses exclusively or primarily on the prevention and control of viral hepatitis: | ||||
 yes | 5 (27.8) | 3 (23.1) | 5 (38.5) | 13 (29.6) |
 no | 13 (78.2) | 10 (76.9) | 8 (61.5) | 31 (70.5) |
If there is a strategy or plan, does it include a surveillance component? | ||||
|  | N = 5 (%) | N = 3 (%) | N = 5 (%) | N = 13 (%) |
 yes | 5 (100) | 3 (100) | 4 (80.0) | 12 (92.3) |
 no | 0 (0) | 0 (0) | 1 (20.0) | 1 (7.7) |
If there is a strategy or plan, is it exclusive for viral hepatitis or does it also address other diseases? | ||||
|  | N = 5 (%) | N = 3 (%) | N = 5 (%) | N = 13 (%) |
 exclusive for viral hepatitis | 1 (20.0) | 1 (33.3) | 2 (40.0) | 4 (30.8) |
 only for HBV | 0 (0) | 1 (33.3) | 0 (0) | 1 (7.7) |
 only for HCV | 1 (20.0) | 0 (0) | 0 (0) | 1 (7.7) |
 integrated with other diseases | 3 (60.0) | 1 (33.3) | 3 (60.0) | 7 (53.8) |